Lastly, it is important to recognize that gastric cancer is a heterogeneous disease, and this study primarily focused on the predictive value of PD-L1 without exploring the correlation with other potential efficacy predictors such as MSI-H and EBER. This evidence concerns the gene CD274 and gastric cancer.